How big is the generative ai in medicine market today, and what are its future growth expectations?
The generative AI in medicine market size has grown exponentially in recent years. It will grow from $0.66 $ billion in 2024 to $0.95 $ billion in 2025 at a compound annual growth rate (CAGR) of 43.9%. The growth in the historic period can be attributed to a rise in computational power and machine learning algorithms, growth in precision medicine, increasing demand for drug discovery, rise in adoption of AI for diagnostic imaging, and growth in investment in AI research and development.
The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $4.02 $ billion in 2029 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to the increasing availability of high-quality medical data, growing focus on preventive healthcare, growing need for efficient clinical trials, increasing demand for AI-enhanced patient engagement tools, and rising use of AI for drug repurposing. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.
Get Your Free Sample of The Global Generative AI in Medicine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19463&type=smp
What have been the primary factors driving the generative ai in medicine market’s growth?
The surge in digital health records is expected to propel the growth of generative artificial intelligence (AI) in medicine market going forward. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, enabling sharing across healthcare settings and improving the efficiency and quality of patient care. The surge in digital health records is driven by improved patient care, increased efficiency in healthcare delivery, regulatory support and incentives, advancements in technology, and enhanced patient engagement and empowerment. Artificial intelligence (AI) in medicine enhances digital health records by automating documentation, structuring data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For instance, in July 2024, according to the European Commission, a Belgium-based executive branch of the European Union, the access to electronic health records score increased to 79% in 2024 from 72% in 2023. Therefore, the surge in digital health records is driving generative artificial intelligence (AI) in medicine market.
What are the key segments within the generative ai in medicine market?
The generative AI in medicinemarket covered in this report is segmented –
1) By Component: Solutions, Service
2) By Function: Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis
3) By Application: Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, Other Applications
4) By End-User: Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End-Users
Subsegments:
1) By Solutions: Diagnostic Tools, Treatment Planning Systems, Personalized Medicine Platforms, Drug Discovery And Development Solutions, Medical Imaging And Analysis Software, Electronic Health Record (EHR) Enhancement Tools
2) By Services: Consulting Services, Implementation And Integration Services, Training And Education Services, Technical Support And Maintenance, Research And Development Services.
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/generative-ai-in-medicine-global-market-report
Which key players are shaping the generative ai in medicine market?
Major companies operating in the generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.
How will emerging trends drive the generative ai in medicine market throughout the forecast period?
Major companies operating in the generative artificial intelligence (AI) in medicine market are focused on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance overall mental health management. AI solutions for brain health and wellness are advanced artificial intelligence technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company focused on developing AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This innovative solution leverages advanced artificial intelligence to evaluate cognitive function and brain wellness comprehensively. Its key features include cutting-edge algorithms that analyze diverse data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, enabling early detection of cognitive issues and tailored interventions.
How do regional factors impact the generative ai in medicine market, and which region is the largest contributor?
North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Generative AI in Medicine Market Report 2025 Offer?
The generative ai in medicine market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Generative artificial intelligence (AI) in medicine refers to using AI systems to generate new data, models, or insights to advance healthcare and medical research. It aims to improve diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19463
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
